Concert Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Concert Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 312% to $32,578,000. Profit margin reached -254%. Total operating expenses were $110,086,000.
Profit Margin
| 2012 | 12.84M | -20.44M | -159.11% |
|---|---|---|---|
| 2013 | 25.40M | -6.05M | -23.84% |
| 2014 | 8.57M | -31.69M | -369.62% |
| 2015 | 66.72M | 24.17M | 36.23% |
| 2016 | 174K | -50.72M | -29149.43% |
| 2017 | 143.89M | 95.63M | 66.47% |
| 2018 | 10.50M | -56.02M | -533.31% |
| 2019 | 1.07M | -77.32M | -7180.04% |
| 2020 | 7.90M | -74.76M | -946.17% |
| 2021 | 32.57M | -82.59M | -253.53% |
CNCE Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 32.57M | 7.90M | 1.07M | 10.50M | 143.89M | 174K | 66.72M | 8.57M | 25.40M | 12.84M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 32.57M | 7.90M | 1.07M | 10.50M | 143.89M | 174K | 66.72M | 8.57M | 25.40M | 12.84M |
Operating exp. | ||||||||||
Research and development | 87.55M | 61.62M | 59.81M | 43.14M | 30.22M | 36.98M | 28.88M | 27.47M | 21.79M | 24.19M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 110.08M | 80.54M | 80.09M | 66.08M | 51.24M | 51.34M | 41.94M | 39.17M | 29.81M | 31.45M |
Operating income | -77.50M | -72.64M | -79.01M | -55.58M | 92.64M | -51.16M | 24.78M | -30.59M | -4.41M | -18.61M |
Other income (expenses), net | -2.54M | -2.20M | 849K | -127K | 2.69M | 447K | -185K | -1.10M | -1.64M | -1.83M |
Income before tax | -80.05M | -74.85M | -78.16M | -55.71M | 95.33M | -50.72M | 24.60M | -31.69M | -6.05M | -20.44M |
Income tax expense | 2.54M | -85K | -837K | 313K | -300K | 447K | 429K | 49K | 21K | 0 |
Net income | -82.59M | -74.76M | -77.32M | -56.02M | 95.63M | -50.72M | 24.17M | -31.69M | -6.05M | -20.44M |
Earnings per share | ||||||||||
Basic EPS | -2.4 | -2.4 | -3.26 | -2.4 | 4.22 | -2.28 | 1.14 | -2 | -0.35 | -1.8 |
Diluted EPS | -2.4 | -2.4 | -3.26 | -2.4 | 4.08 | -2.28 | 1.09 | -2 | -0.35 | -1.8 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |